One email when the rules change

Peptide rules move without much warning. FDA shifts a substance between compounding categories, an advisory committee votes, WADA publishes its next Prohibited List, and a page that was right last month is quietly out of date. This newsletter is one short email when that happens, so you don't have to keep checking.

What you get

A change to a peptide's legal or regulatory status, dated and sourced the way the regulatory tracker is: FDA approvals and compounding-category moves, Pharmacy Compounding Advisory Committee votes and what FDA does with them, WADA list changes, and enforcement actions. After that come new guides, tools and encyclopedia entries, listed underneath the regulatory news and never instead of it. Each item links to the page on this site that changed because of it.

How often

At most one email a week. When nothing changes, nothing arrives: a quiet month means an empty inbox, not a filler issue.

What you won't get

No vendor offers, discount codes, sponsored placements or affiliate links. Grey Peptides sells nothing and links to no seller, and the newsletter follows the same rule.

Where it stands

The newsletter has not started sending. Sign up now and your first email will be its first issue. Until then, the same updates appear as they happen on the News Wire, in the tracker's changelog and in the RSS feed.

What we keep

Your email address and the page you signed up from, nothing else. Our host, Netlify, stores each sign-up as a form submission. Before the first issue goes out we will name the email service on the privacy page, and addresses will move to it only to send this newsletter.

Leaving

Every issue will carry an unsubscribe link. Before launch, or any time, email hello@greypeptides.com and we will delete your address.